The International Atomic Energy Agency (IAEA) announces its intention to hold the International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC2013) running September 30 — October 4, 2013 in Vienna, Austria.
Cardiovascular diseases (CVDs) are an important sub-group of non-communicable diseases and are one of the main priorities in the health care systems of many IAEA Member States. Medical imaging, including molecular nuclear medicine, is extremely important in that it offers strategic advantages in both diagnostic and therapeutic decision making. It provides inputs for diagnosis, staging, treatment, prognosis and follow-up in the management of CVDs. Medical imaging includes techniques such as single photon emission computed tomography (SPECT), positron emission tomography (PET), echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI). These techniques provide an excellent opportunity to understand the pathology of individual patients and can therefore serve to facilitate tailored clinical management. Each imaging modality has its advantages and limitations which need to be understood properly by health care professionals dealing with CVDs.
The IAEA has been applying many approaches for capacity building in Member States to allow them to optimally utilize medical imaging technologies. These approaches have been including training courses, fellowships, expert missions and conferences, to name a few. In November 2011, the International Conference on Clinical PET and Molecular Nuclear Medicine (IPET-2011) was organized to improve the understanding of clinical PET and molecular nuclear medicine among Member States. This was held at the IAEA’s Headquarters in Vienna, Austria, and was extremely well received by Member States. About 350 participants from all over the world benefited from this conference. Using a similar model, it is proposed to hold this International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC2013).
Objectives of the Conference
The conference will cover developments in the entire spectrum of activities related to medical imaging as applied to CVDs. The conference will have the following objectives:
- To evaluate the current status of medical imaging, including SPECT, PET, echocardiography, CT and MRI, in the management of CVDs;
- To reflect on challenges faced in developing countries;
- To deliver supporting ‘know-how’ via continuing medical education programmes in the field, including information on the relative merits and limitations of each imaging modality;
- To improve the performance of clinical practice through ‘read with the experts’ sessions and workshops;
- To interact with the user groups (nuclear physicians, radiologists, cardiologists, technologists, radiographers, radiopharmacists, radiochemists, medical physicists and other scientists working in all aspects of CVD management) and provide them with state-of-the-art information in the field;
- To exchange information on current advances in the field among leading clinical scientists from developed and developing countries;
- To identify future challenges and trends, as well as the role of the IAEA and other international organizations in addressing these.
The IAEA invites participants to provide high quality contributions on all aspects of medical imaging as applied to the management of CVDs. Both academic and practice based papers under the umbrella of the following topics are welcome:
- Member State experience with SPECT, PET, echocardiography, CT and MRI in the management of CVDs;
- Use of hybrid imaging or integrated imaging in CVD management;
- Setting up an integrated imaging facility;
- Radiopharmaceutical production using cyclotrons and radionuclide generators — including good manufacturing practices and quality assurance aspects — with special reference to imaging agents for CVDs;
- Issues of medical physics, instrumentation and image processing and analysis related to CVD imaging;
- Quality management, quality control, quality assurance and audits in integrated medical imaging and nuclear medicine practice;
- Radiation protection for personnel and dose reduction for patients;
- Training and education in integrated medical imaging.
Abstracts, Papers and Proceedings
All papers submitted — other than invited review papers — must present original work and must not have been published elsewhere. Persons who wish to present a poster at the conference must submit an abstract of 500 words maximum on one of the topics listed above.
Expenditures and Grants
No registration fee is charged to participants.
The IAEA is generally not in a position to bear the travel and other costs of designated participants in the conference. The IAEA has, however, limited funds at its disposal to help meet the cost of attendance of certain participants. Such assistance may be offered, upon specific request, to normally one participant per country provided that, in the IAEA’s view, the participant on whose behalf assistance is requested will make an important contribution to the conference. In general, not more than one grant will be awarded to any one country.
If governments wish to apply for a grant on behalf of one of their specialists, they should address specific requests to the IAEA to this effect. Governments should ensure that applications for grants are:
Submitted by 1 March 2013
Accompanied by a duly completed and signed Grant Application Form (Form C)
Accompanied by a completed Participation Form (Form A)
Applications that do not comply with the above conditions cannot be considered. Approved grants will be issued in the form of a lump sum payment that usually covers only part of the cost of attendance.